MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • All Meetings
    • 2026 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • 2023 International Congress

    Incidence and Predictors of Axial Postural Abnormalities in Parkinson disease: data from the PPMI cohort

    CA. Artusi, C. Campisi, C. Ledda, K. Tsukita, D. Rinaldi, L. Lopiano, M. Fabbri (Torino, Italy)

    Objective: We aim to evaluate the incidence of axial postural abnormalities in patients with Parkinson’s disease (PD) and analyze their demographic and clinical predictors. Background:…
  • 2023 International Congress

    Preliminary results of the validation study of the Shame in Parkinson’s disease (SPARK) Scale

    I. Debove, C. Rodriguez-Blazquez, S. Murcia, A. Zenger, MM. Kurtis, E. Cubo, C. Falup-Pecurariu, KR. Chaudhuri, H. Reichman, S. Bostantjopoulou, M. Bereau, V. Fleury, P. Krack (Bern, Switzerland)

    Objective: The goal of this study is to validate the Shame in PARKinson’s disease (SPARK) Scale [1] which identifies the presence, the extent and some…
  • 2023 International Congress

    Pronounced Cervical Dystonia in Ataxia with Vitamin E Deficiency

    M. Soares, T. Guimarães, J. Parmera, M. Oliveira, R. Barbosa, F. Kok, E. Barbosa, R. Cury (São Paulo, Brazil)

    Objective: Objective: To describe a case report of an atypical phenotype of ataxia with vitamin E deficiency (AVED) and marked cervical dystonia. Background: Background: AVED…
  • 2023 International Congress

    Atypical parkinsonism syndromes: clinical presentations

    A. Gunduz, S. Akkus, FZ. Calikusu, E. Koçhan Kızılkılıç, B. Poyraz, A. Altunç, G. Kızıltan (Istanbul, Turkey)

    Objective: Here, our aim was to identify the characteristics of atypical clinical presentations of atypical parkinsonism syndromes in our cohort and our secondary aim was…
  • 2023 International Congress

    Validity and responsiveness of the EQ-5D-3L in Friedreich-Ataxia

    N. Weber, M. Buchholz, A. Rädke, T. Klockgether, B. Michalowsky (Greifswald, Germany)

    Objective: The objective was to validate the well-established EQ-5D in Friedreich’s ataxia (FA). Background: Health-related quality of life (HRQoL) is increasingly researched in FA. The…
  • 2023 International Congress

    Detecting clinical fluctuations in chronic biomarker recordings: experiences with chronic subthalamic peak beta band recordings in a large Parkinson’s disease patient cohort

    LK. Feldmann, J. Habets, V. D'Onofrio, V. Mathiopoulou, J. Busch, K. Faust, GH. Schneider, D. Gruber, G. Ebersbacher, AA. Kühn (Berlin, Germany)

    Objective: Since the understanding of electrophysiological biomarker dynamics during every-day activities is crucial for adaptive deep brain stimulation (aDBS), this study aims to investigate characteristics…
  • 2023 International Congress

    gender differences of fatigue and sleep characteristics in parkinson’s disease patients

    S. Diaconu, S. Berzunteanu, E. Ungureanu, B. Ciopleias, R. Zosin, M. Cusnir, A. Iacob, I. Murasan, B. Ciocanescu, C. Falup-Pecurariu (Brasov, Romania)

    Objective: to study the gender differences in fatigue and sleep characteristics in a cohort of Parkinson’s disease (PD) patients Background: Fatigue is a common problem…
  • 2023 International Congress

    LRRK2 PROTAC® degrader molecules induce robust biomarker responses in preclinical in vivo pharmacology studies following acute and chronic oral dosing

    J. Meredith Jr, K. Kelly, V. Guss, A. Desantis, L. Kimmel, S. Soletsky, J. Pizzano, G. Cadelina, J. Chavez, S. Sparks, A. Cacace (New Haven, USA)

    Objective: Report on the non-clinical in vivo pharmacokinetic and pharmacodynamic biomarker response to PROteolysis TArgeting Chimera (PROTAC®) molecules designed to induce degradation of leucine rich…
  • 2023 International Congress

    Tai Chi training of people with Parkinson’s disease (PD) – neuropsychological and electrophysiological analyses

    U. Gschwandtner, K. Toloraia, M. Atanasova, TM. Al Tawil, S. Elsas, P. Fuhr (Basel, Switzerland)

    Objective: To analyze the influence of Tai Chi training on neurological changes, neuropsychology, quality of life (QoL) and EEG in PD patients. Background: Besides pharmacological…
  • 2023 International Congress

    A human tissue engineered nigrostriatal system as a testbed for understanding PD pathophysiology and therapeutic development

    D. Chouhan, K. Browne, R. Patel, S. Karandikar, F. Laimo, D. Cullen, J. Duda (Philadelphia, USA)

    Objective: The objective of these studies is to develop a tissue engineered nigrostriatal system involving human dopaminergic and striatal cells to recapitulate many of the…
  • « Previous Page
  • 1
  • …
  • 7
  • 8
  • 9
  • 10
  • 11
  • …
  • 186
  • Next Page »

Related Sites

International Parkinson and Movement Disorder Society

The Society that manages the annual International Congress »

International Congress

The official website for the International Congress of Parkinson’s and Movement Disorders® »

  • Help & Support
  • About Us
  • Cookies & Privacy
  • Wiley Job Network
  • Terms & Conditions
  • Advertisers & Agents
Copyright © 2026 International Parkinson and Movement Disorder Society. All Rights Reserved.
Wiley